The test is intended for patients being evaluated for mild cognitive impairment (MCI) or mild dementia clinical stages of Alzheimer's disease.The test measures the amount of beta-amyloid 42 and 40 proteins in the CSF and computes the ratio..
Back to list Go To The Website